Pantoprazole: a new and more specific proton pump inhibitor

Bibliography

• ZECH K, STEINIJANS VW, HUBER R, KOLASSA N, RADTKE
   Google Scholar
• ••HW: Pharmacokinetics and drug interactions - relevantfactors for the choice of a drug. Int J. Clin. Pharmacol (1996) 34\(Suppl. 1):S3–S6.
   Google Scholar
• GARNER A, FADLALLAH H, PARSONS ME: 1976 and all that! - 20 years of antisecretory therapy. Gut (1966) 39:784–786.
   Google Scholar
• KROMER W: Similarities and differences in the proper- ties of substituted benzimidazoles: a comparison be-tween pantoprazole and related compounds. Digestion (1995) 56:443–454.
   PubMed Web of Science ®Google Scholar
• SHIN JM, BESANCON M, SIMON A, SACHS G: The site of action of pantoprazole in the gastric H/K+-ATPase.Biochim. Biophys. Acta (1993) 1148:223–233.
   Google Scholar
• SACHS G, SHIN JM, BESANCON M, PRINZ C: The continu-ing development of gastric proton pump inhibitors. Aliment Pharmacol Ther. (1993) 7\(Suppl. 1):S4–S12.
   Google Scholar
• SIMON WA, KEELING DJ, LAING SM, FALLOWFIELD C, TAYLOR AG: Biochemistry of a novel 01±/K1-ATPase inhibitor. Biochem. Pharmacol (1990) 39:1799–1806.
   PubMed Web of Science ®Google Scholar
• KROMER W, POSTIUS S, RIEDEL R et al: BY 1023/SKF
   Google Scholar
• •96022 INN pantoprazole: a novel gastric proton pump inhibitor, potently inhibits acid secretion but lacks relevant cytochrome P450 interactions. J. Pharmacol Exp. Ther. (1990) 254:129–135.
   PubMed Web of Science ®Google Scholar
• GARNER A, GOODWIN CS, BASTAKI SMA et al.: Compari-son of lansoprazole and omeprazole against gastric H/K-ATPase, II+ secretion and growth of H. pylori. Gut (1996) 39\(Suppl. 3):A143.
   Google Scholar
• POSTIUS S, BRAUER U, KROMER W: The novel proton pump inhibitor pantoprazole elevates intragastric pH for a prolonged period when administered under con-ditions of stimulated gastric acid secretion in the gastric fistula dog. Life Sci. (1991) 49:1047–1052.
   PubMed Web of Science ®Google Scholar
• SUERBAUM S, LEYING H, KLEMM K: Antibacterial activity of pantoprazole and omeprazole against Helicobacter pylori. Eur. Nlicrobiol. Infect. as. (1991) 10:92–92.
   PubMed Web of Science ®Google Scholar
• FITTON A, WISEMAN L: Pantoprazole: a review of its pharmacological properties and therapeutic use in acid-related disorders. Drugs (1996) 51:461–482.
   Google Scholar
• MUSSIG S, WITZEL L: Steady-state intragastric pH profile after 40 mg pantoprazole: comparison of morning and evening administration.Gastroenterology (1993)104:A153.
   Google Scholar
• TUCH K, OCKERT D, REZNIK G: Pantoprazole does not induce gastric carcinoids in a 24 month carcinogenicity study in mice. Pharmacol Toxicol (1993) 73 (Suppl. 2):A75.
   Google Scholar
• LARSSON H, CARLSON E, MATTSSON H et al: Plasma gastrin and gastric enterochromaffin cell activation andproliferation: studies with omeprazole and ranitidine in intact and antrectomised rats. Gastroenterology (1986) 90:391–399.
   Google Scholar
• GARNER A: Gastric tumours induced by antisecretory agents: hypergastrinaemia, structure-activity and other considerations. Res. Clin. Forums (1990) 12:47–57.
   Google Scholar
• ROHR I, OCKERT D, REZNIK GK: Ultrastructural investi-gations oftheentero chromaffin-like (ECL) cells in three different rat strains (Sprague-Dawley, Fischer 344, Wis-tar) after treatment with the 11±/It-ATPase inhibitor pantoprazole. Exp. Toxicol Pathol. (1992) 44:197–200.
   PubMed Web of Science ®Google Scholar
• KOOP H, KULY S, FLUG M: 24-h Intragastric pH and 24-h gastrin profiles during therapy with different doses of the new proton pump inhibitor pantoprazole. Gut (1994) 35\(Suppl. 4):A57.
   Google Scholar
• BRUNNER G, HARKE U: Long-term therapy with pantoprazole in patients with peptic ulceration resistant to extended high-dose ranitidine treatment. Aliment. Phar-macol Ther. (1994) 8\(Suppl. 0:59–64.
   Google Scholar
• MCCOLL KEL, NUJUMI AM, DORRIAN CA: Helicobacter pylori and hypergastrinaemia during proton pump inhibitor therapy. Scand. j Gasfroenterol (1992) 27:93–98.
   Google Scholar
• DAMMANN HG, BETHKE T, BURKHARDT F: Effects of pantoprazole on endocrine function in healthy male volunteers. Aliment Pharmacol Ther. (1994) 8:549–554.
   PubMed Web of Science ®Google Scholar
• ARNOLD R: Safety of proton pump inhibitors - an overview. Aliment Pharmacol. Ther. (1994) 8\(Suppl. 0:65–70.
   Google Scholar
• HUBER R, HARTMANN M, BLIESATH R et al.: Pharmacokinetics of pantoprazole in man. Int. J. Clin. Pharmacol (1996) 34\(Suppl. 1):S7–S16.
   Google Scholar
• BREUEL HP, HARTMANN M, BONDY S: Pantoprazole in the elderly: no dose adjustment. Gut (1994) 35\(Suppl. 4):A77.
   Google Scholar
• LINS RL, DE CLERCQ I, HARTMANN M: Pharmacokinetics of the proton pump inhibitor pantoprazole in patients with severe renal impairment. Gastroenterology (1994) 106:A126.
   Web of Science ®Google Scholar
• STEINIJANS VW, HUBER R, HARTMANN M et al.: Lack of pantoprazole drug interactions in man: an updated review. Int.Pharmacol (1996) 34 (Suppl. 1):S31–S50.
   Google Scholar
• MIDDLE M, MUELLER F: Pantoprazole does not impair the efficacy of hormonal contraception. Gastroenterol-ogy (1994) 106:A139.
   Web of Science ®Google Scholar
• KOOP H, SCHEPP W, DAMMANN HG et al.: Comparative trial of pantoprazole and ranitidine in the treatment of reflux esophagitis: a German multicentre study. J. Clin. Gasfroenterol. (1995) 20:192–195.
   Google Scholar
• VON KLEIST DH, BOSSECKERT H, SCHOLLENT: Pantopra-zole versus ranitidine in acid-related disease. Gastroen-terology (1996) 110:A228.
   Google Scholar
• DAMMANN HG, HAHN EG, ADLER G, SCHLANDER M: Pantoprazole is more effective than famotidine in acute gastro-oesophage al reflux disease. Gastroenterology (1996) 110:A89.
   Web of Science ®Google Scholar
• BELAICHF J, COLIN R, CORINALDESI R: Efficacy of panto-prazole compared to omeprazole in reflux esophagitis. 10th World Congress of Gastroenterology. Los Angeles (1994). Abstract 2556P.
   Google Scholar
• CORINALDESI R, VALENTINI M, BELAICHE J et al: Panto-prazole and omeprazole in the treatment of reflux oesophagitis: a European multicentre study. Aliment. Pharmacol. Ther. (1995) 9:667–671.
   Google Scholar
• HOTZ J, GANGL A, HEINZERLING H: Pantoprazole versus omeprazole in acute reflux esophagitis. Gastroenterology (1996) 110:A136.
   Web of Science ®Google Scholar
• HOTZ J, PLEIN K, SCHONEKAS H, ROSE K: Pantoprazole is superior to ranitidine in the treatment o f acute gastric ulcer. Scand. Gasfroenterol. (1995) 30:111–115.
   Google Scholar
• ARENDT R, PORST H, ROHNER HG et al.: Peptic ulcer recurrence following treatment with pantoprazole or ranitidine. Gut (1995) 37 (Suppl. 2):A 1 1 .
   Google Scholar
• WITZEL L, GUTZ H, HUTTEMANN W, SCHEPP W: Panto-prazole versus omeprazole in the treatment of acute gastric ulcers. Aliment. Pharmacol Ther. (1995) 9:19–24.
   PubMed Web of Science ®Google Scholar
• VAN RENSBURG CJ, VAN EEDEN PJ, MARKS IN: Improved duodenal ulcer healing with pantoprazole compared with ranitidine: a multicentre study. Eur. j Gastroenterol Hepatol. (1994) 6:739–43.
   Google Scholar
• DIBILDOX M, TOMAS-PONS J, ROSE K et al.: Clinical superiority of pantoprazole over ranitidine inthe treat-ment of patients with florid duodenal ulcers: Mexican multicentre study. Gut (1995) 37 (Suppl. 2) :A16.
   Google Scholar
• JUDMAIER G, KOELZ HR: Pantoprazole and ranitidine in the treatment of acute duodenal ulcer. Aliment Pharma-col. Ther. (1994) 8:81–86.
   Google Scholar
• CREMER M, LAMBERT R, LAMERS CBH, DELLE FAVE G, MATER C: A double-blind study of pantoprazole and ranitidine in treatment of acute duodenal ulcer: a multi-centre trial. Dig Dis. Sci. (1995) 40:1360–1364.
   Google Scholar
• SCHEPP W, CLASSEN M: Pantoprazole and ranitidine in the treatment of acute duodenal ulcer. Scand. J. Gastroen-terol. (1995) 30:511–514.
   PubMed Web of Science ®Google Scholar
• BACCARO JC, BESASSO H, DAVOLOS JR: Pantoprazole is superior to ranitidine in the treatment of florid duode-nal ulcer. Gastroenterology (1996) 110:A54.
   Web of Science ®Google Scholar
• DIETRICH K, KOSLING M, ROSPRICH G, BETHKE T, ROHNER HG: Time course of recurrence following duo-denal ulcer healing with pantoprazole or ranitidine. Gut (1994) 35\(Suppl. 4):A72.
   Google Scholar
• HAHN EG, DAMMANN HG: Pantoprazole provides faster healing and pain relief than famotidine in acute duode-nal ulcer disease. Gastroenterology (1996) 110:A127.
   Web of Science ®Google Scholar
• BEKER JA, BIANCHI PORRO G, BIGARD MA eta].: Double-blind comparison of pantoprazole and omeprazole for the treatment of acute duodenal ulcer. Eur. j Gastroen-terol. Hepatol. (1995) 7:407–410.
   Google Scholar
• REHNER M, ROHNER HG, SCHEPP W: Comparison of pantoprazole versus omeprazole in the treatment of acute duodenal ulceration-a multicentre study. Aliment Pharmacol Ther. (1995) 9:411–416.
   PubMed Web of Science ®Google Scholar
• RAUWS EAJ, VAN DER HULST RWM: Current guidelines for the eradication of Helicobacter pylori in peptic ulcer disease. Drugs (1995) 50:984–990.
   Google Scholar
• HUERLIMANN R, FLUECKIGER TH: One week eradication of Helicobacter pylori with clarithromycin, metronida-zole and a proton pump blacker. Schweizerisch Medische Wochenschrift (1995) 125:11S.
   PubMedGoogle Scholar
• HARRIS A, MISIEWICZ JJ: Treating Helicobacter pylori - the best is yet to come? Gut (1996) 39:781–783.
   Google Scholar
• ADAMEK RJ: Pantoprazole, clarithromycin and me troni-dazole vs. pantoprazole and clarithromycin for cure of Helicobacter pylori infection in duodenal ulcer pa-tients. Gastroenterology (1996) 110:A48.
   Google Scholar
• LABENZ J, PEITZ U, TILLENBURG B, BECKER T, STOLTE M: Efficacy and tolerability of a one-week low-dose triple therapy consisting of pantoprazole, clarithromycin and metronidazole for cure of Helicobacter pylori infection. Gut (1995) 37 (Suppl. 2) :A24.
   Google Scholar
• BARDHAN KD, SLATER DN: Pantoprazole (panto)-based
   Google Scholar
• -day triple therapy is effective for Helicobacter pylori eradication. Gastroenterology (1996) 110:A48.
   Google Scholar
• LOUVV JA, MARKS IN, VAN RENSBURG CJ et al.: The effectof pantoprazole, as monotherapy and in combination with amoxicillin, on gastric H. pylori status, in duode-nal ulcer subjects. Gut (1994) 37\(Suppl. 2):A63.
   Google Scholar
• BARDHAN KD, CHERIAN P: Pantoprazole (panto) in aggressive or refractory acid-peptic disease. Gastroen-terology (1996) 110:A57.
   Web of Science ®Google Scholar
• PARSONS ME, GARNER A: Drug development in gastr oenterology: the changing view of industry. Aliment. Phar-macol Ther. (1995) 9:457–463.
   Google Scholar
• LEE A, BUCK F: Vaccination and mucosal responses to
   Google Scholar
• •Helicobacter pylori infection. Aliment. Pharmacol. Ther. (1996) 10\(Suppl. 0:129–138.
   Google Scholar